HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 39 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $28,302 | +171.1% | 36,448 | +4.8% | 0.00% | – |
| Q4 2022 | $10,439 | -70.2% | 34,785 | -49.8% | 0.00% | – |
| Q3 2022 | $35,000 | +34.6% | 69,261 | +52.6% | 0.00% | – |
| Q2 2022 | $26,000 | -74.8% | 45,400 | -42.9% | 0.00% | – |
| Q1 2022 | $103,000 | +7.3% | 79,553 | -6.1% | 0.00% | – |
| Q4 2021 | $96,000 | +17.1% | 84,721 | +56.3% | 0.00% | – |
| Q3 2021 | $82,000 | -79.0% | 54,189 | -72.6% | 0.00% | – |
| Q2 2021 | $391,000 | +64.3% | 197,809 | +53.1% | 0.00% | – |
| Q1 2021 | $238,000 | +30.8% | 129,212 | +55.2% | 0.00% | – |
| Q4 2020 | $182,000 | +20.5% | 83,279 | +71.7% | 0.00% | – |
| Q3 2020 | $151,000 | – | 48,512 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 189,616 | $375,439,000 | 1.17% |
| Ikarian Capital, LLC | 1,365,059 | $2,703,000 | 0.22% |
| Altium Capital Management LP | 446,000 | $883,000 | 0.20% |
| ASSET MANAGEMENT CORP /IL/ /ADV | 91,500 | $181,000 | 0.10% |
| Virtu Financial LLC | 113,869 | $225,000 | 0.02% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 10,000 | $20,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 155,069 | $307,000 | 0.01% |
| McAdam, LLC | 55,978 | $86,000 | 0.01% |
| Moloney Securities Asset Management, LLC | 27,340 | $54,000 | 0.01% |
| Allen Capital Group, LLC | 23,685 | $47,000 | 0.01% |